Exploring Key Insights of the Preclinical Imaging Market: Growth Prospects, Emerging Trends, and Opportunities
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
What key factors are powering the surge in the preclinical imaging market right now?
The size of the preclinical imaging market has seen significant growth in the past few years. This sector is projected to increase from $3.46 billion in 2024 to $3.69 billion in 2025, with a compound annual growth rate (CAGR) of 6.7%. The expansion during the historical period can be traced back to government initiatives, a surge in the disease prevalence, broadening applications, heightened awareness, and the growth of emerging markets.
How fast Is the preclinical imaging market expected to grow, and what’s its future value?
Growth is projected to be robust in the preclinical imaging market in the coming years, with an expectation to reach $4.83 billion in 2029, exhibiting a compound annual growth rate (CAGR) of 6.9%. The potential surge during the forecast period can be accredited to factors such as the adoption of personalized medicine, advancements in the field of molecular imaging, outsourcing of drug development, supportive regulatory environment, and an increase in chronic diseases. The forecast period is also expected to witness key trends including the emergence of green imaging technologies, technological evolutions, a surge in research and development activities, collaborations and partnerships, and the introduction of real-time imaging.
Get your preclinical imaging market report here!
https://www.thebusinessresearchcompany.com/report/preclinical-imaging-global-market-report
What are the leading drivers of growth in the preclinical imaging market?
The rising prevalence of chronic illnesses is predicted to drive the expansion of the preclinical imaging market. Chronic illnesses are long-lasting health issues that typically persist for three months or more, often requiring continuous medical management and significantly affecting an individual’s quality of life. Preclinical imaging devices are utilized to identify these diseases by visualizing skeletal structures and lung functionalities. They are also employed to analyze how these diseases develop over time and improve understanding of the disease. For example, the World Health Organization (WHO) 2022 Highlights, a Switzerland-based intergovernmental health organization reported in September 2022, that annually worldwide Noncommunicable diseases (NCDs) or chronic diseases accounted for 41 million deaths, which is 74% of all deaths. Among these 17.9 million are due to cardiovascular diseases, 9.3 million to cancer, 4.1 million to chronic respiratory diseases, and 2.0 million to diabetes. As such, the surge in chronic disease is fostering the growth of the preclinical imaging market.
What are the key segments defining the preclinical imaging market?
The preclinical imaging market covered in this report is segmented –
1) By Modality: Optical Imaging Systems, Preclinical Nuclear Imaging Systems, Micro-Magnetic Resonance Imaging Systems, Micro-Ultrasound Systems, Micro-Computed Tomography Systems, Preclinical Photoacoustic Imaging Systems, Preclinical Magnetic Particle Imaging (MPI) Systems
2) By Reagents: Preclinical Optical Imaging Reagents, Preclinical Nuclear Imaging Reagents, Preclinical MRI Contrast Agents, Preclinical Ultrasound Contrast Agents, Preclinical CT Contrast Agents
3) By End User: Hospital, Diagnostics Center, Other End-User
Subsegments:
1) By Optical Imaging Systems: Bioluminescence Imaging, Fluorescence Imaging
2) By Preclinical Nuclear Imaging Systems: Positron Emission Tomography (PET), Single-Photon Emission Computed Tomography (SPECT)
3) By Micro-Magnetic Resonance Imaging (Micro-MRI) Systems: High-Resolution Micro-MRI Systems, Functional Micro-MRI Systems
4) By Micro-Ultrasound Systems: High-Frequency Ultrasound Imaging, Real-Time Micro-Ultrasound Systems
5) By Micro-Computed Tomography (Micro-CT) Systems: In Vivo Micro-CT Systems, Ex Vivo Micro-CT Systems
6) By Preclinical Photoacoustic Imaging Systems: Multi-Wavelength Photoacoustic Imaging, Hybrid Photoacoustic Imaging Systems
7) By Preclinical Magnetic Particle Imaging (MPI) Systems: MPI For Cell Tracking, MPI For Vascular Imaging
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12393&type=smp
Who are the key players steering the development of the preclinical imaging market?
Major companies operating in the preclinical imaging market include Thermo Fisher Scientific Inc., FUJIFILM Visualsonics Inc., Konica Minolta Inc., Agilent Technologies Inc., PerkinElmer Inc., Bio-Rad Laboratories Inc., Bruker Corporation, Miltenyi Biotech, Sofie Biosciences Inc., Promega Corporation, Ion Beam Applications S.A, Nihon Kohden, Piramal Enterprises Ltd, LI-COR Biosciences Inc., Aspect Imaging Ltd, Capintec Inc., Spectral Instruments Inc., Mediso Ltd, MR Solutions Ltd, Biospace Lab S. A., Scintica Instrumentation Inc., Trifoil Imaging, Bioscan Inc., CytoSMART Technologies B.V, Inviscan SAS, Kubtec X-ray, MILabs B.V., SCANCO Medical AG, Cristal Therapeutics.
What emerging trends are influencing the growth of the preclinical imaging market?
The surge in product innovations is a trend that is rapidly gaining traction in the preclinical imaging market. Top corporations that are active in this market are innovating product designs to maintain a competitive edge. One such example is Fujifilm VisualSonics Inc., a biomedical firm based in Canada that specializes in the production of imaging systems. In May 2022, the company introduced a revolutionary product called Vevo F2, tailored for preclinical imaging. Vevo F2 is the inaugural preclinical imaging system that varies in ultrasound and photoacoustic scanning from ultra-high- to low-frequency (71 MHz–1 MHz). It incorporates HD image processing technology and an entirely new signal pathway, delivering improved image clarity and faster frame rates. The system can also be tailored to meet the exact precision requirements for imaging. Other distinctive features of this system include its customizable system architecture, potential to target various anatomical structures, and high-definition imaging. It is adaptable for use in a range of research scenarios.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12393
Which regions are most influential in expanding the preclinical imaging market?
North America was the largest region in the preclinical imaging market in 2024. The regions covered in the preclinical imaging market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Browse Through More Similar Reports By The Business Research Company:
Brain And Neuroimaging Devices Global Market Report 2024
Dental Diagnostic Imaging Devices And Equipment Global Market Report 2024
Breast Imaging Devices Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/breast-imaging-devices-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
